StockData

Mosaic ImmunoEngineering Inc. (CPMV) stock

CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.33+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Mosaic ImmunoEngineering gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Mosaic ImmunoEngineering

Mosaic ImmunoEngineering has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Mosaic ImmunoEngineering figures

See a number that looks wrong?